# Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

> **NCT06064071** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Candela Corporation** · enrollment: 100 (estimated)

## Conditions studied

- Meibomian Gland Dysfunction
- Dry Eye Disease

## Interventions

- **DEVICE:** Nordlys SWT IPL
- **PROCEDURE:** Meibomian Gland Expression (MGX)
- **DEVICE:** Sham Nordlys SWT IPL

## Key facts

- **NCT ID:** NCT06064071
- **Lead sponsor:** Candela Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-18
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06064071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06064071, "Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06064071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*